TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List February 7, 1992
TCL Archive Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study December 31, 2010